share_log

Spyre Therapeutics Shares Are Trading Lower. The Company Announced Interim Phase 1 Data From Its First-in-human Trial of SPY001.

Benzinga ·  Nov 13 02:20
Spyre Therapeutics Shares Are Trading Lower. The Company Announced Interim Phase 1 Data From Its First-in-human Trial of SPY001.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment